Journey Medical (DERM) Share-based Compensation (2020 - 2026)

Journey Medical has reported Share-based Compensation for 7 years, with the latest figure at $989000.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 25.25% year-over-year to $989000.0; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (down 1.01% YoY), and the FY2025 full-year result was $6.3 million, up 3.12% from the prior year.
• Share-based Compensation for Q1 2026 stood at $989000.0, down from $1.8 million in the prior quarter.
• The five-year high for Share-based Compensation was $1.9 million in Q3 2025, with the low at $529000.0 in Q4 2023.
• Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $1.3 million in 2025.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 17875.0% — and 2023, when it plunged 63.26%.
• Journey Medical's Share-based Compensation stood at $1.4 million in 2022, then sank by 63.26% to $529000.0 in 2023, then surged by 160.49% to $1.4 million in 2024, then rose by 28.81% to $1.8 million in 2025, then tumbled by 44.28% to $989000.0 in 2026.
• The last three Share-based Compensation figures came in at $989000.0 (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.